MORPHOSYS AG | 124.60 / +0.56% |
Date/Time | 12/11 / 17:29 |
Chg. / Chg.(%) | 0.70 / +0.56% |
Bid | 124.50 / 28 |
Ask | 124.60 / 26 |
Open | 124.20 |
Previous Close | 123.90 |
High | 124.60 |
Low | 122.90 |
Volume [EUR] | 1,250,189.85 |
Volume [Units] | 10,105 |
Price fixings | 251 |
ISIN | DE0006632003 |
Security | MOR/D |
Exchange | Turquoise |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 124.40 | ![]() |
155,830 |
Cboe Europe .. | 124.60 | ![]() |
18,841 |
Cboe Europe .. | 124.60 | ![]() |
16,389 |
London Inter.. | 123.25 | ![]() |
13,903 |
Turquoise | 124.60 | ![]() |
10,105 |
TradeGate | 124.500 | ![]() |
9,511 |
Stuttgart | 124.600 | ![]() |
1,911 |
Nasdaq Other.. | 138.0000 | ![]() |
500 |
Frankfurt | 124.4000 | ![]() |
338 |
Düsseldorf | 124.40 | ![]() |
133 |
München | 123.60 | ![]() |
100 |
Hamburg | 123.00 | ![]() |
40 |
Vienna Globa.. | 124.60 | ![]() |
0 |
Hannover | 124.10 | ![]() |
0 |
Berlin | 124.00 | ![]() |
0 |
SIX Swiss Ex.. | 102.00 | ![]() |
|
Lang & Schwa.. | 124.100 | ![]() |
|
gettex | 124.000 | ![]() |
|
EUREX | Options |
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire